Hal M. Hoffman
Impact in
- Immunology top 0.2%
- IL-33, ST2, and ILC Pathways
- Immune Response and Inflammation
- interferon and immune responses
- Nephrology top 0.2%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Inflammasome and immune disorders 101
- Immunology 64
- IL-33, ST2, and ILC Pathways 22
- Immune Response and Inflammation 18
- Co-authors
- James L. Mueller (23 shared papers)Alan A. Wanderer (9 shared papers)David H. Broide (13 shared papers)Lori Broderick (26 shared papers)Matthew D. McGeough (23 shared papers)Richard D. Kolodner (7 shared papers)Alexander Wree (15 shared papers)Ariel E. Feldstein (15 shared papers)
- Journals
- The Journal of Immunology (11 papers)Journal of Allergy and Clinical Immunology (8 papers)Hepatology (5 papers)The Journal of Experimental Medicine (5 papers)Scientific Reports (4 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Hal M. Hoffman
155 papers receiving 18.4k citations
Hal M. Hoffman's Hit Papers
Peers
Comparison fields: 5 of 147
- Immunology 5.9k
- Nephrology 1.5k
- Molecular Biology 11.7k
- Hematology 1.4k
- Biological Psychiatry 278
Countries citing papers authored by Hal M. Hoffman
This map shows the geographic impact of Hal M. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hal M. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hal M. Hoffman more than expected).
Fields of papers citing papers by Hal M. Hoffman
This network shows the impact of papers produced by Hal M. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hal M. Hoffman. The network helps show where Hal M. Hoffman may publish in the future.
Co-authors
The 25 scholars most cited alongside Hal M. Hoffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Hit paper breakdown → | 2012 | 1984 |
| 2 | Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome Hit paper breakdown → | 2001 | 1311 |
| 3 | NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria Hit paper breakdown → | 2016 | 988 |
| 4 | NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice Hit paper breakdown → | 2013 | 807 |
| 5 | Glyburide inhibits the Cryopyrin/Nalp3 inflammasome Hit paper breakdown → | 2009 | 700 |
| 6 | Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity Hit paper breakdown → | 2005 | 594 |
| 7 | Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling Hit paper breakdown → | 2022 | 525 |
| 8 | From NAFLD to NASH to cirrhosis—new insights into disease mechanisms Hit paper breakdown → | 2013 | 505 |
| 9 | 2008 | 480 | |
| 10 | 2004 | 458 | |
| 11 | Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis Hit paper breakdown → | 2020 | 431 |
| 12 | NLRP3 inflammasome activation is required for fibrosis development in NAFLD Hit paper breakdown → | 2014 | 416 |
| 13 | Inflammasome activation leads to Caspase-1–dependent mitochondrial damage and block of mitophagy Hit paper breakdown → | 2014 | 406 |
| 14 | 2018 | 380 | |
| 15 | 2007 | 306 | |
| 16 | 2009 | 283 | |
| 17 | 2006 | 276 | |
| 18 | 2004 | 253 | |
| 19 | 2009 | 245 | |
| 20 | 2001 | 245 |
About Hal M. Hoffman
Hal M. Hoffman is a scholar working on Molecular Biology, Immunology, Surgery, Nephrology and Epidemiology, having authored 160 papers that have together received 18.9k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (101 papers), IL-33, ST2, and ILC Pathways (22 papers), Immune Response and Inflammation (18 papers), Gout, Hyperuricemia, Uric Acid (16 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Liver Disease Diagnosis and Treatment (11 papers), Urticaria and Related Conditions (10 papers) and Streptococcal Infections and Treatments (9 papers). The work is most often cited by research in Immunology (5.9k citations), Nephrology (1.5k citations), Molecular Biology (11.7k citations), Hematology (1.4k citations) and Biological Psychiatry (278 citations). Hal M. Hoffman has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include James L. Mueller, Alan A. Wanderer, David H. Broide, Lori Broderick, Matthew D. McGeough, Richard D. Kolodner, Alexander Wree, Ariel E. Feldstein, Carla A. Peña and Ali Canbay. Their work appears in journals such as The Journal of Immunology, Journal of Allergy and Clinical Immunology, Hepatology, The Journal of Experimental Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.